Researcher profile

Jeffrey S. Morris

Jeffrey S. Morris contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2021arXiv

Bayesian Edge Regression in Undirected Graphical Models to Characterize Interpatient Heterogeneity in Cancer

Graphical models are commonly used to discover associations within gene or protein networks for complex diseases such as cancer. Most existing methods estimate a single graph for a population, while in many cases, researchers are interested in characterizing the heterogeneity of individual networks across subjects with respect to subject-level covariates. Examples include assessments of how the network varies with patient-specific prognostic scores or comparisons of tumor and normal graphs while accounting for tumor purity as a continuous predictor. In this paper, we propose a novel edge regression model for undirected graphs, which estimates conditional dependencies as a function of subject-level covariates. Bayesian shrinkage algorithms are used to induce sparsity in the underlying graphical models. We assess our model performance through simulation studies focused on comparing tumor and normal graphs while adjusting for tumor purity and a case study assessing how blood protein networks in hepatocellular carcinoma patients vary with severity of disease, measured by HepatoScore, a novel biomarker signature measuring disease severity.

preprint2019arXiv

Function-on-Scalar Quantile Regression with Application to Mass Spectrometry Proteomics Data

Mass spectrometry proteomics, characterized by spiky, spatially heterogeneous functional data, can be used to identify potential cancer biomarkers. Existing mass spectrometry analyses utilize mean regression to detect spectral regions that are differentially expressed across groups. However, given the inter-patient heterogeneity that is a key hallmark of cancer, many biomarkers are only present at aberrant levels for a subset of, not all, cancer samples. Differences in these biomarkers can easily be missed by mean regression, but might be more easily detected by quantile-based approaches. Thus, we propose a unified Bayesian framework to perform quantile regression on functional responses. Our approach utilizes an asymmetric Laplace working likelihood, represents the functional coefficients with basis representations which enable borrowing of strength from nearby locations, and places a global-local shrinkage prior on the basis coefficients to achieve adaptive regularization. Different types of basis transform and continuous shrinkage priors can be used in our framework. A scalable Gibbs sampler is developed to generate posterior samples that can be used to perform Bayesian estimation and inference while accounting for multiple testing. Our framework performs quantile regression and coefficient regularization in a unified manner, allowing them to inform each other and leading to improvement in performance over competing methods as demonstrated by simulation studies. We also introduce an adjustment procedure to the model to improve its frequentist properties of posterior inference. We apply our model to identify proteomic biomarkers of pancreatic cancer that are differentially expressed for a subset of cancer patients compared to the normal controls, which were missed by previous mean-regression based approaches. Supplementary materials for this article are available online.